- COMMENT
Show them the money: a multi-stakeholder perspective on reforming clinical trial participant compensation
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature Reviews Drug Discovery 23, 881-882 (2024)
doi: https://doi.org/10.1038/d41573-024-00107-2
References
Largent, E. A. & Lynch, H. F. Paying research participants: regulatory uncertainty, conceptual confusion, and a path forward. Yale J. Health Policy Law Ethics 17, 61–141 (2017).
Gelinas, L. et al. Framework for Ethical Payment to Research Participants. N. Engl. J. Med. 378, 766–771 (2018).
Bierer, B. E., White, S. A., Gelinas, L. & Strauss, D. H. Fair payment and just benefits to enhance diversity in clinical research. J. Clin. Transl. Sci. 5, e159 (2021).
Cryder, C. E., London, A. J., Volpp, K. G. & Loewenstein, G. Informative inducement: study payment as a signal of risk. Soc. Sci. Med. 70, 455–464 (2010).
Halpern, S. D., Karlawish, J. H. T., Casarett, D., Berlin, J. A. & Asch, D. A. Empirical assessment of whether moderate payments are undue or unjust inducements for participation in clinical trials. Arch. Intern. Med. 164, 801–803 (2004).
Competing Interests
The authors declare no competing interests.